CMOPF (Cosmo Pharmaceuticals NV) Accumulated Depreciation : $0.0 Mil (As of Jun. 2024)

View and export this data going back to 2016. Start your Free Trial

What is Cosmo Pharmaceuticals NV Accumulated Depreciation?

Note: A negative number here means the assets are depreciated. When depricates more, the absolute value gets bigger.

Cosmo Pharmaceuticals NV's quarterly accumulated depreciation increased from Jun. 2023 ($0.0 Mil) to Dec. 2023 ($-55.3 Mil) but then stayed the same from Dec. 2023 ($-55.3 Mil) to Jun. 2024 ($0.0 Mil).

Cosmo Pharmaceuticals NV's annual accumulated depreciation increased from Dec. 2021 ($-46.7 Mil) to Dec. 2022 ($-48.6 Mil) and increased from Dec. 2022 ($-48.6 Mil) to Dec. 2023 ($-55.3 Mil).

Cosmo Pharmaceuticals NV Accumulated Depreciation Historical Data

The historical data trend for Cosmo Pharmaceuticals NV's Accumulated Depreciation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cosmo Pharmaceuticals NV Accumulated Depreciation Chart

Cosmo Pharmaceuticals NV Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Accumulated Depreciation

Get a 7-Day Free Trial

-37.94

-45.34

-46.72

-48.57

-55.33

Cosmo Pharmaceuticals NV Semi-Annual Data
	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24
Accumulated Depreciation	Get a 7-Day Free Trial															-	-48.57	-	-55.33	-

Cosmo Pharmaceuticals NV Accumulated Depreciation Calculation

The cumulative depreciation of an asset up to a single point in its life. Regardless of the method used to calculate it, the depreciation of an asset during a single period is added to the previous period's accumulated depreciation to get the current accumulated depreciation.

Cosmo Pharmaceuticals NV Accumulated Depreciation Related Terms

Thank you for viewing the detailed overview of Cosmo Pharmaceuticals NV's Accumulated Depreciation provided by GuruFocus.com. Please click on the following links to see related term pages.

Cosmo Pharmaceuticals NV Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Cosmo Pharmaceuticals NV (OTCPK:CMOPF) » Definitions » Accumulated Depreciation

Comparable Companies

Traded in Other Exchanges

COPNz:UK 0RGI:UK C43:Germany COPN:Switzerland

Address

Sir John Rogerson’s Quay, Riverside II, Dublin, IRL, 2

Website

https://www.cosmopharma.com

Cosmo Pharmaceuticals NV is a pharmaceutical company with a focus on gastrointestinal diseases, dermatology and healthtech. The company develops and manufactures products that are distributed globally by its partners. Products that the company has developed include Lialda/Mezavant/Mesavancol and Uceris/Cortiment, for the treatment of ulcerative colitis; GI Genius, which uses artificial intelligence to aid the detection of colorectal polyps during colonoscopy; Eleview, a submucosal injectable composition for use in gastrointestinal endoscopic procedures; Aemcolo for the treatment of travellers' diarrhoea (TD) and Winlevi for the treatment of acne. Product pipeline includes Breezula, GI Genius, Methylene blue MMX, Aemcolo, CB-03-10 and CB-01-33.